The NACE Clinical Highlights Show
NACE
Engage with expert NACE faculty for discussions about current clinical strategies for common and rare health conditions that you can use in clinical practice immediately, and that work for you and your patients.
All episodes
Best episodes
Seasons
Top 10 The NACE Clinical Highlights Show Episodes
Goodpods has curated a list of the 10 best The NACE Clinical Highlights Show episodes, ranked by the number of listens and likes each episode have garnered from our listeners. If you are listening to The NACE Clinical Highlights Show for the first time, there's no better place to start than with one of these standout episodes. If you are a fan of the show, vote for your favorite The NACE Clinical Highlights Show episode by adding your comments to the episode page.
APAPP Imposter Syndrome/ Who me?
The NACE Clinical Highlights Show
08/01/24 • 28 min
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
The NACE Journal Club with Dr. Neil Skolnik - #2
The NACE Clinical Highlights Show
02/15/23 • 25 min
The NACE Journal Club with Dr. Neil Skolnik, is a new series of episodes that provide review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
- Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture Major Extremity Trauma Research Consortium (METRC), N Engl J Med 2023; 388:203-213
Guest: Marissa Norden, DO, 2nd year resident Jefferson Health Abington - Long-term Weight Training and Mortality in U.S. Male Health Professionals With and Without Type 2 Diabetes Dong Hoon Lee et.al.;Diabetes Care 2023;46(1):138–148
Guest: Matt Rubin, MD, attending physician at Main Line Health - Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low- Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease Ann Intern Med. 2023 Jan;176(1):I18. doi: 10.7326/P22-0022. Epub 2022 Dec 13.
Guest: Gabriella Petrongolo, DO, 2nd year resident Jefferson Health Abington - Associations of Physical Inactivity and COVID-19 Outcomes - American Journal of Preventive Medicine Young DR, Sallis JF, Baecker A, Cohen DA, Nau CL, Smith GN, Sallis RE.;Am J Prev Med. 2022 Dec 10:S0749-3797(22)00526-8. doi: 10.1016/j.amepre.2022.10.007. Epub ahead of print.
Guest: Alex Fierstein, DO, 3rd year resident Jefferson Health Abington
Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
The APAPP Podcast Ep. 4: The Devil in the Details: How to Dissect Research Articles
The NACE Clinical Highlights Show
08/01/23 • 38 min
Show Notes
All is not as it seems? Dr. Alain Eid’s passion for research and years of experience as a principal investigator on innumerable studies helps us learn how to pick apart research articles and not to take them at face value. Take a deeper dive and strengthen your knowledge in evidence based medicine.
NACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP). APAPP is the first association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work together for the advancement of the profession and for the well-being of patients with pulmonary diseases. To learn more about APAPP and to get involved, please visit https://www.pulmapp.com.
Guest
Alain Eid, MD
Alain Eid, MD is a 1991 graduate from St. Joseph University Medical School (Lebanon). He received his Medical school training in the hospitals of Paris, France. He completed his residency in Internal Medicine at St. John Hospital, Detroit. He finished his fellowship in Pulmonary Medicine and Critical Care at the Oklahoma University Medical Center. He was appointed Associate Professor of Pulmonary and Critical Care Medicine from 1998 through 2004 at the Oklahoma University. He is board Certified in Critical Care, Pulmonary Medicine and Sleep Medicine. Dr. Eid has a special interest and vast experience in lung cancer diagnosis and management. He developed the Lung nodule Clinic/ Lung cancer center at the VA of Oklahoma City. Once in Colorado Springs, he championed the development of the lung Cancer Center at Memorial Hospital and then at Penrose Hospital.
Host
Corinne R. Young, MSN, FNP-C, FCCP
Director of APP and Clinical Services, Colorado Springs Pulmonary Consultants
President, APAPP, Colorado Springs, CO
Corinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne. To that end, Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.
In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.
This Podcast episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
APAPP Critical Care Edition: PREOXI Trial
The NACE Clinical Highlights Show
01/01/25 • 36 min
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
CME/CE Podcast: Mastering The Mixes
The NACE Clinical Highlights Show
09/16/24 • 20 min
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
https://www.mycme.com/courses/navigating-the-complexities-of-mixed-mood-states-9705
Summary
Mixed episode bipolar disorders are now referred to as "mixed features" they occur when a person experiences symptoms of depression and mania simultaneously, according to the latest edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM). This shift reflects a broader understanding of the condition. Understanding and distinguishing these mixed mood states across Bipolar I, Bipolar II, and MDD is crucial for accurate diagnosis and management. Additionally, reviewing existing evidence on the efficacy, tolerability, and safety of treatments tailored to these conditions is essential for optimizing patient outcomes.
In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic dive into the complexities of mixed mood states in Bipolar I, Bipolar II, and Major Depressive Disorder (MDD). These mixed states involve the simultaneous experience of both manic or hypomanic and depressive symptoms, creating a unique challenge for diagnosis and treatment. This podcast will distinguish these mixed mood states across different disorders and review the latest evidence on the efficacy, tolerability, and safety of treatments designed to manage these challenging conditions.
This podcast/webcast was recorded and is being used with permission of the presenters.
Learning Objectives
At the conclusion of this activity, participants should be better able to:
- Distinguish mixed mood states associated with Bipolar I, Bipolar II, and MDD
- Review existing evidence pertaining to efficacy and tolerability/safety of treatments for Bipolar I, Bipolar II, and MDD with mixed features
This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at [email protected].
Summary of Individual Disclosures
Please review faculty and planner disclosures here.
Disclosure of Commercial Support
This educational activity is not commercially funded.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
CME/CE PODCAST: Recognizing the Burden of Residual Symptoms in MDD
The NACE Clinical Highlights Show
06/27/24 • 29 min
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
https://www.mycme.com/courses/recognizing-the-burden-of-residual-symptoms-in-mdd-9526
Summary
Early and effective treatment of major depressive disorder (MDD) is essential to prevent persistent residual symptoms, which are associated with worse outcomes. Evidence indicates that residual symptoms, such as impaired cognition, are underrecognized and undertreated in routine clinical care. Recognizing residual symptoms and the factors contributing to suboptimal treatment response is a critical first step to modifying management, with the goal of eliminating residual symptoms and achieving full remission.
In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss common residual symptoms and other signs of suboptimal treatment response, including the impact of antidepressant side effects and the efficacy of antidepressants for residual symptoms.
This podcast/webcast was recorded and is being used with permission of the presenters.
This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.25 hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at [email protected].
Summary of Individual Disclosures
Please review faculty and planner disclosures here.
Disclosure of Commercial Support
This educational activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
CME/CE Podcast: Candid Conversations about Menopause Treatment Barriers
The NACE Clinical Highlights Show
04/17/24 • 23 min
https://www.mycme.com/courses/candid-conversations-about-menopause-treatment-barriers-9387Summary
Join Dr. Genevieve Neil-Perry as she moderates a dynamic panel discussion on the obstacles hindering access to quality menopause treatment. Dr. Gregg Sherman (primary care) and Dr. Nanette Santoro (OB/GYN) bring their clinical perspectives, while a patient joins and shares their firsthand experiences.
This episode explores the unique challenges faced by patients and providers within the menopause care landscape. The panel delves into potential solutions, aiming to empower listeners with knowledge and strategies to overcome these barriers for improved menopause care.
Learning Objective
- Identify patient and clinician barriers to management of menopausal symptoms
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which does not include hours of pharmacology ).
For additional information about the accreditation of this program, contact NACE at [email protected].
Summary of Individual Disclosures
Angela Golden has disclosed the following financial relationships:
- Consultant: Novo Nordisk (obesity), Lilly (obesity), Acella (thyroid), Currax (obesity), Boehringer Ingelheim (obesity), WW (obesity), Gelesis (obesity - relationship has ended)
- Speaker: Novo Nordisk (obesity), Lilly (obesity), Acella (thyroid), Currax (obesity)
- Receipt of Royalty: Springer (obesity - relationship has ended), Amazon (fiction)
Bernadette Makar has no relevant financial relationships to disclose.
Gregg Sherman has no relevant financial relationships to disclose.
Genevieve Neal-Perry has disclosed the following financial relationships:
- Scientific Advisory Board: Astellas (women’s health), Natera (women’s health)
- Review Panel: SRI (professional organization)
- Consultant: Astellas Pharma, MenoGeniX, Ansh Labs
- All disclosures are related to women's health.
Disclosure of Commercial Support
This educational activity is
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
The APAPP Podcast Ep. 10: Idiopathic Shortness of Breath Part 2: Dysfunctional Breathing Clinic
The NACE Clinical Highlights Show
03/01/24 • 29 min
NACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP). APAPP is the first association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work together for the advancement of the profession and for the well-being of patients with pulmonary diseases. To learn more about APAPP and to get involved, please visit https://www.pulmapp.com.
Guest
Cori Fratelli, RN, MSN, FNP-C
Nurse Practitioner
Division of Pulmonary, Critical Care & Sleep Medicine
Department of Medicine
I have a unique background in both basic science and clinical research, which has informed my interest in clinical medicine. My past basic science research includes asthma, airway hyperresponsiveness, cystic fibrosis, and lung cancer. My past clinical research includes COPD and interstitial lung disease (ILD). Presently, I am interested in how research translates into personalized medicine. My clinical focus is mainly ILD, but I also see general pulmonary medicine patients, as needed.
Host
Corinne R. Young, MSN, FNP-C, FCCP
Director of APP and Clinical Services, Colorado Springs Pulmonary Consultants
President, APAPP, Colorado Springs, CO
Corinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne. To that end, Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.
In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.
This Podcast episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
CME/CE Podcast: Using GLP-1 RAs to Reduce CV Risk in T2D
The NACE Clinical Highlights Show
10/13/23 • 13 min
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
https://www.mycme.com/courses/using-glp-1-ras-to-reduce-cv-risk-in-t2d-9134
Summary
Type 2 diabetes (T2D) doubles a patient’s risk for atherosclerotic cardiovascular disease (ASCVD), which is the leading cause of morbidity and mortality in patients with T2D. The 2023 ADA guidelines now recommend consideration of GLP-1 RAs in patients with T2D and ASCVD or indicators of ASCVD risk, independently of A1C and metformin use. In this episode, Dr. Pam Taub reviews recent updates in the cardiovascular benefits and appropriate use of GLP-1 receptor agonists for managing patients with T2D.
Learning Objectives
- Incorporate early use of GLP-1 RA therapy in appropriate patients with T2D using a holistic approach, considering administration route and optimal dosing
- Overcome barriers to GLP-1 RA uptake and medication adherence in T2D through patient counseling to manage adverse effects
This activity is accredited for CME/CE Credit
Association of Black Cardiologists, Inc. (ABC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Association of Black Cardiologists, Inc. (ABC) designates this enduring material for a maximum of 0.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and ABC. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).
For additional information about the accreditation of this program, contact NACE at [email protected].
Summary of Individual Disclosures
Dr. Taub financial relationships:
Consultant: Amgen, Bayer, Boehringer Ingelheim, Novartis, Novo Nordisk, Esperion, Merck, Sanofi, Medtronic
Contracted Research: Amgen, Novartis
All her disclosures are related to cardiology
Dr. Morris financial relationships:
Consultant and advisor: Acorai, Regeneron, Merck
Speaker: Abbott, BI Lilly, Cytokinetics, Edwards Lifesciences, Ionis
Contracted Research: Boston Scientific, Cytokinetics, Ionis, Merck, Myokardia, Novartis
Stocks: Gilead Sciences
All her disclosures are related to heart failure.
All of the relevant financial relationships listed for these individuals have been mitigated.
Association of Black Cardiologists Planning Committee
Tierra Dillenburg has no relevant conflicts of interest with any ACCME-defined commercial interest.
Faculty, planners, guest patient(s) (if applicable), and moderators for this educational activity not listed in the Summary of Individual Disclosures above have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Disclosure of Commercial Support
This educational activity is supported by an independent educational grant from Novo Nordisk Inc.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
APAPP New PAH Therapies in 2024
The NACE Clinical Highlights Show
10/01/24 • 34 min
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Show more best episodes
Show more best episodes
FAQ
How many episodes does The NACE Clinical Highlights Show have?
The NACE Clinical Highlights Show currently has 99 episodes available.
What topics does The NACE Clinical Highlights Show cover?
The podcast is about Health & Fitness, Nutrition, Nurse Practitioner, Vaccine, Cme, Mental Health, Medicine, Podcasts, Diabetes, Covid-19, Education and Primary Care.
What is the most popular episode on The NACE Clinical Highlights Show?
The episode title 'CME/CE Deep Dive into 5: Answering Your Questions on Asthma Biologics' is the most popular.
What is the average episode length on The NACE Clinical Highlights Show?
The average episode length on The NACE Clinical Highlights Show is 25 minutes.
How often are episodes of The NACE Clinical Highlights Show released?
Episodes of The NACE Clinical Highlights Show are typically released every 6 days, 3 hours.
When was the first episode of The NACE Clinical Highlights Show?
The first episode of The NACE Clinical Highlights Show was released on Sep 25, 2020.
Show more FAQ
Show more FAQ